Solid Biosciences, Inc. (SLDB)
5.87
0.00 (0.00%)
USD |
NASDAQ |
Dec 12, 16:00
5.855
-0.02
(-0.26%)
After-Hours: 20:00
Solid Biosciences Cash from Investing (Quarterly): -45.27M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 17.01M |
| Travere Therapeutics, Inc. | 86.59M |
| Xenetic Biosciences, Inc. | 0.00 |
| KalVista Pharmaceuticals, Inc. | -- |
| BeyondSpring, Inc. | 1.616M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -33.47M |
| Cash from Financing (Quarterly) | 1.176M |
| Free Cash Flow | -133.17M |
| Free Cash Flow Per Share (Quarterly) | -0.3554 |
| Free Cash Flow to Equity (Quarterly) | -32.44M |
| Free Cash Flow to Firm (Quarterly) | -33.56M |
| Free Cash Flow Yield | -30.49% |